Mycoses in AIDS

Author: Dupont B.   Brown H. H. Crewe   Westermann K.   Martins M. D.   Rex J. H.   Lortholary O.   Kauffmann C. A.  

Publisher: Informa Healthcare

ISSN: 1460-2709

Source: Medical Mycology, Vol.38, Iss.1, 2000-12, pp. : 259-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Major changes are occurring in the epidemiology of opportunistic infections (OI) in patients with acquired immune deficiency syndrome (AIDS) and treated with highly active antiretroviral therapy (HAART). A marked decrease of minor and major OI was observed and clinical resistance of thrush to antifungal agents became extremely rare. Primary and secondary prophylaxis against Pneumocystis carinii infections can be stopped; however, the situation is less clear for other OI such as cryptococcosis or endemic mycoses. The epidemiology is dramatically different in the countries which cannot afford the cost of HAART for the majority of patients, such as South Africa. These topics will be discussed in this paper.